Genzyme extends Bioenvision tender offer
CAMBRIDGE, Mass., July 2 (UPI) -- U.S. firm Genzyme said Monday it has waived its tender-offer condition to buy at least half of the outstanding common shares of Bioenvision.

| Stories | Photos | People | Comments |
View Caption